Autopsy report · NCT00037115
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
Cause of deathFunding or business
“Lack of funding”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
- Sponsor type
- University, hospital or other
- Conditions
- Demyelinating Disorders; Multiple Sclerosis; Optic Neuritis; Myelitis; Neuritis
- Interventions
- interferon beta 1a; methotrexate; methylprednisolone
- Participants
- 0
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.